Joanna Szwiec-Tomiczek
Opole, OP, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
BRCA1 promoter hypermethylation is not associated with germline variants in Polish breast cancer patients.
Journal: Hereditary cancer in clinical practice
Published: April 17, 2025
Blood molybdenum level as a marker of cancer risk on BRCA1 carriers.
Journal: Hereditary cancer in clinical practice
Published: August 01, 2024
Antioxidant Properties of Zinc and Copper-Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers.
Journal: Antioxidants (Basel, Switzerland)
Published: June 05, 2024
Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers.
Journal: Nutrients
Published: March 26, 2024
Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 Carriers.
Journal: Nutrients
Published: March 23, 2024
Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers.
Journal: Antioxidants (Basel, Switzerland)
Published: March 23, 2024
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor.
Journal: Hereditary cancer in clinical practice
Published: December 22, 2021
Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?
Journal: Cancers
Published: October 11, 2021
The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.
Journal: British journal of cancer
Published: September 22, 2021
Last Updated: 09/26/2026